Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Lisini

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Blood|July 27, 2006
Emergence of antitumor cytolytic T cells is associated with maintenance of hematologic remission in children with acute myeloid leukemiaDaniela Montagna, Rita Maccario, Franco Locatelli, et al.
Blood|February 7, 2004
T lymphocytes of recipient origin may contribute to the recovery of specific immune response toward viruses and fungi in children undergoing cord blood transplantationDaniela Montagna, Franco Locatelli, Antonia Moretta, et al.
Experimental Hematology|June 27, 2006
Donor multipotent mesenchymal stromal cells may engraft in pediatric patients given either cord blood or bone marrow transplantationSara Pozzi, Daniela Lisini, Marina Podestà, et al.
Cytotherapy|July 8, 2019
Generation of donor-derived Wilms tumor antigen 1-specific cytotoxic T lymphocytes with potent anti-leukemia activity for somatic cell therapy in children given haploidentical stem cell transplantation: a feasibility pre-clinical studyFederica Ferulli, Matteo Tanzi, Ilaria Turin, et al.
Experimental Hematology|October 31, 2003
Generation and ex vivo expansion of cytotoxic T lymphocytes directed toward different types of leukemia or myelodysplastic cells using both HLA-matched and partially matched donorsDaniela Montagna, Rita Maccario, Enrica Montini, et al.
Journal of Translational Medicine|April 11, 2014
In vitro biosafety profile evaluation of multipotent mesenchymal stem cells derived from the bone marrow of sarcoma patientsEnrico Lucarelli, Chiara Bellotti, Melissa Mantelli, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 3, 2018
In Vitro Killing of Colorectal Carcinoma Cells by Autologous Activated NK Cells is Boosted by Anti-Epidermal Growth Factor Receptor-induced ADCC Regardless of RAS Mutation StatusIlaria Turin, Sara Delfanti, Federica Ferulli, et al.
British Journal of Haematology|September 25, 2009
Germ-line mutation of the NRAS gene may be responsible for the development of juvenile myelomonocytic leukaemiaPaola De Filippi, Marco Zecca, Daniela Lisini, et al.
Pharmaceutics|May 6, 2020
Automated Large-Scale Production of Paclitaxel Loaded Mesenchymal Stromal Cells for Cell Therapy ApplicationsDaniela Lisini, Sara Nava, Simona Frigerio, et al.
Immunology Letters|October 4, 2015
Expression and function of toll-like receptors in human circulating endothelial colony forming cellsIolanda Mazzucchelli, Daniela Lisini, Francesca Garofoli, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Blood|July 27, 2006
Emergence of antitumor cytolytic T cells is associated with maintenance of hematologic remission in children with acute myeloid leukemiaDaniela Montagna, Rita Maccario, Franco Locatelli, et al.
Blood|February 7, 2004
T lymphocytes of recipient origin may contribute to the recovery of specific immune response toward viruses and fungi in children undergoing cord blood transplantationDaniela Montagna, Franco Locatelli, Antonia Moretta, et al.
Experimental Hematology|June 27, 2006
Donor multipotent mesenchymal stromal cells may engraft in pediatric patients given either cord blood or bone marrow transplantationSara Pozzi, Daniela Lisini, Marina Podestà, et al.
Cytotherapy|July 8, 2019
Generation of donor-derived Wilms tumor antigen 1-specific cytotoxic T lymphocytes with potent anti-leukemia activity for somatic cell therapy in children given haploidentical stem cell transplantation: a feasibility pre-clinical studyFederica Ferulli, Matteo Tanzi, Ilaria Turin, et al.
Experimental Hematology|October 31, 2003
Generation and ex vivo expansion of cytotoxic T lymphocytes directed toward different types of leukemia or myelodysplastic cells using both HLA-matched and partially matched donorsDaniela Montagna, Rita Maccario, Enrica Montini, et al.
Journal of Translational Medicine|April 11, 2014
In vitro biosafety profile evaluation of multipotent mesenchymal stem cells derived from the bone marrow of sarcoma patientsEnrico Lucarelli, Chiara Bellotti, Melissa Mantelli, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 3, 2018
In Vitro Killing of Colorectal Carcinoma Cells by Autologous Activated NK Cells is Boosted by Anti-Epidermal Growth Factor Receptor-induced ADCC Regardless of RAS Mutation StatusIlaria Turin, Sara Delfanti, Federica Ferulli, et al.
British Journal of Haematology|September 25, 2009
Germ-line mutation of the NRAS gene may be responsible for the development of juvenile myelomonocytic leukaemiaPaola De Filippi, Marco Zecca, Daniela Lisini, et al.
Pharmaceutics|May 6, 2020
Automated Large-Scale Production of Paclitaxel Loaded Mesenchymal Stromal Cells for Cell Therapy ApplicationsDaniela Lisini, Sara Nava, Simona Frigerio, et al.
Immunology Letters|October 4, 2015
Expression and function of toll-like receptors in human circulating endothelial colony forming cellsIolanda Mazzucchelli, Daniela Lisini, Francesca Garofoli, et al.
Pageof 4